These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 25353265

  • 1. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A, Tinguely M, Pfaltz M, Burghart DR, Kempf W.
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [Abstract] [Full Text] [Related]

  • 2. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W, Kutzner H, Cozzio A, Sander CA, Pfaltz MC, Müller B, Pfaltz M.
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF, Jansen PM, Meijer CJ, Willemze R.
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [Abstract] [Full Text] [Related]

  • 4. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA, Su A, Ra S, Cappel MA, Louissant A, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D.
    Am J Surg Pathol; 2014 Sep; 38(9):1203-11. PubMed ID: 24805854
    [Abstract] [Full Text] [Related]

  • 5. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
    Ferrara G, Ena L, Cota C, Cerroni L.
    Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
    [Abstract] [Full Text] [Related]

  • 6. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis.
    McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C.
    J Cutan Pathol; 2014 Feb; 41(2):88-100. PubMed ID: 24118002
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous CD30-positive lymphoproliferative disorders with CD8 expression: a clinicopathologic study of 21 cases.
    Plaza JA, Feldman AL, Magro C.
    J Cutan Pathol; 2013 Feb; 40(2):236-47. PubMed ID: 23189966
    [Abstract] [Full Text] [Related]

  • 8. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
    Hagiwara M, Tomita A, Takata K, Shimoyama Y, Yoshino T, Tomita Y, Nakamura S.
    Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
    [Abstract] [Full Text] [Related]

  • 9. CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: a report of two cases and analysis of CD30 expression.
    Gill K, Ariyan C, Wang X, Brady MS, Pulitzer M.
    J Surg Oncol; 2014 Sep; 110(3):258-64. PubMed ID: 24891295
    [Abstract] [Full Text] [Related]

  • 10. Pityriasis lichenoides et varioliformis acuta with numerous CD30(+) cells: a variant mimicking lymphomatoid papulosis and other cutaneous lymphomas. A clinicopathologic, immunohistochemical, and molecular biological study of 13 cases.
    Kempf W, Kazakov DV, Palmedo G, Fraitag S, Schaerer L, Kutzner H.
    Am J Surg Pathol; 2012 Jul; 36(7):1021-9. PubMed ID: 22472952
    [Abstract] [Full Text] [Related]

  • 11. Pathobiology of CD30+ cutaneous T-cell lymphomas.
    Kadin ME.
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
    [Abstract] [Full Text] [Related]

  • 12. Death receptor apoptosis signaling mediated by FADD in CD30-positive lymphoproliferative disorders involving the skin.
    Clarke LE, Bayerl MG, Bruggeman RD, Mauger D, Ioffreda MD, Abou-Elella A, Helm KF.
    Am J Surg Pathol; 2005 Apr; 29(4):452-9. PubMed ID: 15767797
    [Abstract] [Full Text] [Related]

  • 13. DUSP22-rearranged primary cutaneous CD30-positive T-cell lymphoproliferative disorders and adult T-cell leukemia/lymphoma frequently share the LEF1+/TIA1- immunophenotype.
    Chen BJ, Hsieh SM, Hsieh TH, Jhuang JY, Kao YC.
    Hum Pathol; 2024 Aug; 150():58-66. PubMed ID: 38971328
    [Abstract] [Full Text] [Related]

  • 14. Potential involvement of Notch1 signalling in the pathogenesis of primary cutaneous CD30-positive lymphoproliferative disorders.
    Kamstrup MR, Ralfkiaer E, Skovgaard GL, Gniadecki R.
    Br J Dermatol; 2008 Apr; 158(4):747-53. PubMed ID: 18241263
    [Abstract] [Full Text] [Related]

  • 15. Epstein-Barr virus in CD30 anaplastic large cell lymphoma involving the skin and lymphomatoid papulosis in South Korea.
    Kim YC, Yang WI, Lee MG, Kim SN, Cho KH, Lee SJ, Lee MW, Koh JK.
    Int J Dermatol; 2006 Nov; 45(11):1312-6. PubMed ID: 17076712
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the tumor microenvironment in primary cutaneous CD30-positive lymphoproliferative disorders: a predominance of CD163-positive M2 macrophages.
    De Souza A, Tinguely M, Burghart DR, Berisha A, Mertz KD, Kempf W.
    J Cutan Pathol; 2016 Jul; 43(7):579-88. PubMed ID: 27080437
    [Abstract] [Full Text] [Related]

  • 17. CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
    Paulli M, Berti E, Rosso R, Boveri E, Kindl S, Klersy C, Lazzarino M, Borroni G, Menestrina F, Santucci M.
    J Clin Oncol; 1995 Jun; 13(6):1343-54. PubMed ID: 7751878
    [Abstract] [Full Text] [Related]

  • 18. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
    De Souza A, Carter JB, Harris NL, Ferry JA, Duncan LM.
    J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
    [Abstract] [Full Text] [Related]

  • 19. Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
    Kadin ME.
    Oncology (Williston Park); 2009 Nov 30; 23(13):1158-64. PubMed ID: 20043465
    [Abstract] [Full Text] [Related]

  • 20. Spectrum of CD30+ lymphoid proliferations in the eyelid lymphomatoid papulosis, cutaneous anaplastic large cell lymphoma, and anaplastic large cell lymphoma.
    Sanka RK, Eagle RC, Wojno TH, Neufeld KR, Grossniklaus HE.
    Ophthalmology; 2010 Feb 30; 117(2):343-51. PubMed ID: 19969358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.